Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up
- Resource Type
- Article
- Source
- In
Annals of Oncology February 2011 22(2):452-457 - Subject
- Language
- ISSN
- 0923-7534